Japan has seen a spate of recent developments that will help to predict worsening symptoms in COVID-19 patients. This includes…...
Please subscribe to read the full story.
Pharma
Keio University Venture Looks to Achieve Breakthrough in Cardiovascular Regenerative Medicine
Heartseed Inc., a venture company out of Keio University, has its eyes set on bringing about a new cardiovascular regenerative…...
Please subscribe to read the full story.
Gunze Sees Bioabsorbable Materials as Backbone to Medical Division
Gunze Ltd. (TYO:3002) is expanding its lineup of bioabsorbable materials as it aims to quickly reach 10 billion yen ($94.81…...
Please subscribe to read the full story.
